Cargando…

Editorial: Approaches to Address Resistance, Drug Discovery, and Vaccine Development in Mycobacterium tuberculosis: Challenges and Opportunities

Detalles Bibliográficos
Autores principales:	Sharma, Sandeep, Sharma, Divakar, Kalia, Nitin Pal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106390/ https://www.ncbi.nlm.nih.gov/pubmed/35572633 http://dx.doi.org/10.3389/fmicb.2022.871464

Ejemplares similares

Functional Characterization of PknI-Rv2159c Interaction in Redox Homeostasis of Mycobacterium tuberculosis
por: Venkatesan, Arunkumar, et al.
Publicado: (2016)

Editorial: Drug-resistant Mycobacterium tuberculosis
por: Boshoff, Helena I. M., et al.
Publicado: (2023)

Role of Bacterioferritin & Ferritin in M. tuberculosis Pathogenesis and Drug Resistance: A Future Perspective by Interactomic Approach
por: Sharma, Divakar, et al.
Publicado: (2017)

Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis
por: Sharma, Divakar, et al.
Publicado: (2017)

Cytosolic Proteome Profiling of Aminoglycosides Resistant Mycobacterium tuberculosis Clinical Isolates Using MALDI-TOF/MS
por: Sharma, Divakar, et al.
Publicado: (2016)

Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis
por: Machado, Diana, et al.
Publicado: (2018)

M. tuberculosis Hypothetical Proteins and Proteins of Unknown Function: Hope for Exploring Novel Resistance Mechanisms as well as Future Target of Drug Resistance
por: Sharma, Divakar, et al.
Publicado: (2017)

Editorial: Evolution and genomics of the Mycobacterium tuberculosis complex
por: Guimaraes, Ana M. S., et al.
Publicado: (2023)

Commentary: Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates
por: Sharma, Sandeep, et al.
Publicado: (2017)

Tolerance and Persistence to Drugs: A Main Challenge in the Fight Against Mycobacterium tuberculosis
por: Boldrin, Francesca, et al.
Publicado: (2020)

How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery
por: Bhagwat, Amala, et al.
Publicado: (2022)

Molecular mechanisms of underlying genetic factors and associated mutations for drug resistance in Mycobacterium tuberculosis
por: Swain, Shasank S., et al.
Publicado: (2020)

Editorial: Tuberculosis Drug Discovery & Development: Drug Targets, Chemical Matter, and Approaches
por: Singh, Vinayak
Publicado: (2021)

Editorial: New insights in Mycobacterium tuberculosis
por: Natarajaseenivasan, Kalimuthusamy
Publicado: (2022)

Editorial: Genomics-based strategies for advanced drug resistance and epidemiological surveillance of Mycobacterium tuberculosis and other non-tuberculous mycobacteria
por: Ghodousi, Arash, et al.
Publicado: (2023)

The Macrophage Response to Mycobacterium tuberculosis and Opportunities for Autophagy Inducing Nanomedicines for Tuberculosis Therapy
por: Maphasa, Retsepile E., et al.
Publicado: (2021)

Editorial: Computational drug discovery for emerging viral infections
por: Skariyachan, Sinosh, et al.
Publicado: (2023)

Anti-tuberculosis drug development via targeting the cell envelope of Mycobacterium tuberculosis
por: Xu, Xinyue, et al.
Publicado: (2022)

Editorial: Opportunities and Challenges for Drug Discovery From Natural Products in Pharmacotherapy of Neurological Disorders
por: Jeandet, Philippe, et al.
Publicado: (2022)

Editorial: Cellular and Molecular Mechanisms of Mycobacterium tuberculosis Virulence
por: Sun, Jianjun, et al.
Publicado: (2019)

The Iron Response of Mycobacterium tuberculosis and Its Implications for Tuberculosis Pathogenesis and Novel Therapeutics
por: Rodriguez, G. Marcela, et al.
Publicado: (2022)

Editorial: Investigating Antimicrobial Resistance With Single-Molecule Sequencing Technologies: Opportunities and Challenges
por: Li, Ruichao, et al.
Publicado: (2022)

Editorial: Antifungal Drug Discovery: New Theories and New Therapies
por: Seneviratne, Chaminda J., et al.
Publicado: (2016)

Editorial: Cancer diagnosis and novel drug discovery based on microbiome
por: Chen, Peng, et al.
Publicado: (2023)

VapC21 Toxin Contributes to Drug-Tolerance and Interacts With Non-cognate VapB32 Antitoxin in Mycobacterium tuberculosis
por: Sharma, Arun, et al.
Publicado: (2020)

An Update on CFTR Drug Discovery: Opportunities and Challenges
por: D’Ursi, Pasqualina, et al.
Publicado: (2022)

AI in drug discovery: Applications, opportunities, and challenges
por: Bittner, Martin-Immanuel, et al.
Publicado: (2022)

Deuterium in drug discovery: progress, opportunities and challenges
por: Di Martino, Rita Maria Concetta, et al.
Publicado: (2023)

House of cellulose - a new hideout for drug tolerant Mycobacterium tuberculosis
por: Kumar, Ashwani
Publicado: (2016)

Strategies to Address Challenges in Neuroscience Drug Discovery and Development
por: O’Donnell, Patricio, et al.
Publicado: (2019)

Comparative Proteomic Analysis of Aminoglycosides Resistant and Susceptible Mycobacterium tuberculosis Clinical Isolates for Exploring Potential Drug Targets
por: Sharma, Divakar, et al.
Publicado: (2015)

Interplay between Mutations and Efflux in Drug Resistant Clinical Isolates of Mycobacterium tuberculosis
por: Machado, Diana, et al.
Publicado: (2017)

Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment
por: Allué-Guardia, Anna, et al.
Publicado: (2021)

Mycobacterium tuberculosis Next-Generation Whole Genome Sequencing: Opportunities and Challenges
por: Iketleng, Thato, et al.
Publicado: (2018)

Editorial: New Approaches Against Drug-Resistant M. tuberculosis
por: Av-Gay, Yossef, et al.
Publicado: (2021)

Editorial: Intranasal Drug Delivery: Challenges and Opportunities
por: Fortuna, Ana, et al.
Publicado: (2022)

Conditional Silencing by CRISPRi Reveals the Role of DNA Gyrase in Formation of Drug-Tolerant Persister Population in Mycobacterium tuberculosis
por: Choudhary, Eira, et al.
Publicado: (2019)

Transcriptional regulation and drug resistance in Mycobacterium tuberculosis
por: Miotto, Paolo, et al.
Publicado: (2022)

The evolving biology of Mycobacterium tuberculosis drug resistance
por: Jones, Richard M., et al.
Publicado: (2022)

Prevalence of Multi-Drug Resistant Mycobacterium Tuberculosis in Khyber Pakhtunkhwa – A High Tuberculosis Endemic Area of Pakistan
por: ALI, SAJID, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uqpahl332d4tooicofbn8vm6nh